CORT CORCEPT THERAPEUTICS INC

Did the company actually spend money buying back stock in 3+ of the last 4 quarters?

Bought back stock in 4/4 quarters. Q2 2026: $103M, Q1 2026: $27M, Q3 2025: $12M, Q2 2025: $3M

Is the most recent quarter's buyback spend more than 15% above the trailing average?

Latest quarter $103M vs trailing avg $14M (+625%)

What percentage of free cash flow is going to buybacks? Bull: 30%+. Bear: negative FCF or no buybacks.

Negative FCF ($-40M), buybacks not supported by cash flow

How fast are they shrinking the float? Bull: 2%+ annually. Bear: under 0.5%.

Repurchased 30,800,000 shares = 36.4% of 112,710,000 outstanding (annualized)

Are officers and directors buying stock with their own money on the open market?

2 open-market purchases by 1 insiders

• BAKER G LEONARD JR () bought 75,782 shares at $33.00 on 2026-03-17
• BAKER G LEONARD JR () bought 24,218 shares at $33.56 on 2026-03-17

Are both company buybacks and insider buying independently active? Bull when the company is buying back stock in 2+ quarters and insiders have made 2+ open-market purchases.

Company buybacks in 4 quarters and 2 insider purchases by 1 insiders (no calendar overlap, but both independently active)

Over the last 90 days, are insiders net buyers or net sellers on the open market?

Insiders bought $0M, sold $56M in the last 90 days (net selling)

Active buyback + insiders net selling 3x+ more than buying. Company cash may be supporting price while insiders exit.

Company buying back stock while insiders sold 30.9x more than bought. 5 C-suite officers among sellers

• Vieira Roberto Wandenkolk (President, Oncology) sold 296 shares on 2026-09-16
• Vieira Roberto Wandenkolk (President, Oncology) sold 23,600 shares on 2026-09-02
• Vieira Roberto Wandenkolk (President, Oncology) sold 23,770 shares on 2026-09-02
• Vieira Roberto Wandenkolk (President, Oncology) sold 1,537 shares on 2026-09-02
• Vieira Roberto Wandenkolk (President, Oncology) sold 974 shares on 2026-09-02
• Vieira Roberto Wandenkolk (President, Oncology) sold 1,606 shares on 2026-09-02
• Vieira Roberto Wandenkolk (President, Oncology) sold 5,621 shares on 2026-09-02
• Vieira Roberto Wandenkolk (President, Oncology) sold 1,225 shares on 2026-09-02
• Robb Gary Charles (Chief Business Officer) sold 10,000 shares on 2026-08-17
• Guyer William (Chief Development Officer) sold 11,530 shares on 2026-08-10